Johnson & Johnson Medical Companies broke ground for its new Ethicon factory on Thursday in Suzhou of East China’s Jiangsu province, in an attempt to address the health problems faced in the country.
The new Ethicon factory has attracted a total investment of $180 million. The factory will be responsible for the manufacturing of Johnson & Johnson’s patented medical devices, such as triclosan-coated sutures, endoscopic staplers and linear cutters. These surgical products will be used to treat critical diseases such as lung cancer, liver cancer and gastric cancer.
This is the first time that Johnson & Johnson has brought the production line of the minimally invasive and open surgical solutions to China. It is also the first of its kind outside the United States. Covering 14,776 square meters, the Ethicon factory will be put into operation in two phases: first in the fourth quarter of 2019 and second in the third quarter of 2020.